European Journal of Cancer
Volume 39, Issue 9 , Pages 1194-1198, June 2003

Levels of absolute survival benefit for systemic therapies of advanced cancer:

a call for standards

  • J.P.A. Ioannidis

      Affiliations

    • Clinical Trials and Evidence-Based Medicine Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina 45110, Greece
    • Division of Clinical Care Research, Tufts-New England Medical Center, Boston, MA, USA
    • ,
  • N. Pavlidis

      Affiliations

    • Division of Medical Oncology, Department of Medicine (NP), University of Ioannina School of Medicine, Ioannina 45110, Greece
    • Corresponding Author InformationCorresponding author. Tel.: +30-2-6510-97505

Received 3 January 2003; accepted 8 January 2003.

Full Text Available

  • Purchase this article for  31.50 USD

    Access is available for 24 hours.

    (Login or Register to purchase)

  • Subscribe to this title
  • Claim access now

    Current subscribers


    • PII: S0959-8049(03)00119-9

    doi:10.1016/S0959-8049(03)00119-9

    European Journal of Cancer
    Volume 39, Issue 9 , Pages 1194-1198, June 2003